RTC13 structure
|
Common Name | RTC13 | ||
---|---|---|---|---|
CAS Number | 1359825-94-7 | Molecular Weight | 315.30 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C14H9N3O4S | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of RTC13RTC13 restores dystrophin expression and improves muscle function in the mdx mouse model for Duchenne muscular dystrophy (DMD)[1]. |
Name | RTC13 |
---|---|
Synonym | More Synonyms |
Description | RTC13 restores dystrophin expression and improves muscle function in the mdx mouse model for Duchenne muscular dystrophy (DMD)[1]. |
---|---|
Related Catalog | |
In Vivo | Animal Model: Wild-type (C57BL/10) mice at 10 to 12 weeks of age[1]. Dosage: 10 (n = 5), 30 (n = 5), 60 (n = 5) or 300 mg/kg (n = 5). Administration: Intraperitoneal Administration. Result: No changes were observed in liver and kidney weights at the time of necropsies, and Hematoxylin and Eosin (H&E) staining revealed the absence of histopathological changes. |
References |
Molecular Formula | C14H9N3O4S |
---|---|
Molecular Weight | 315.30 |
Exact Mass | 315.03100 |
PSA | 139.71000 |
LogP | 3.44290 |
(5Z)-2-Amino-5-[[5-(2-nitrophenyl)-2-furanyl]methylene]-4(5H)-thiazolone |
(Z)-2-amino-5-((5-(2-nitrophenyl)furan-2-yl)methylene)thiazol-4(5H)-one |
4(5H)-Thiazolone, 2-amino-5-[[5-(2-nitrophenyl)-2-furanyl]methylene]-, (5Z)- |